Skin immunization with influenza vaccines

Current Topics in Microbiology and Immunology

Volumn 386, Issue , 2014, Pages 343-369

  Skountzou, Ioanna ^a   Compans, Richard W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; DNA VACCINE; IMIQUIMOD; IMMUNOLOGICAL ADJUVANT; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY; POLYINOSINIC POLYCYTIDYLIC ACID; QS 21; QUIL A; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; TRIPLE VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN PRESENTING CELL; ARTICLE; CHICKEN; CROSS REACTION; DENDRITIC CELL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; EQUIPMENT DESIGN; GENE GUN; GUINEA PIG; HEMAGGLUTINATION INHIBITION; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; INNATE IMMUNITY; JET INJECTOR; LANGERHANS CELL; MATERIAL COATING; MICRONEEDLE; MOUSE; NONHUMAN; POWDER; PRIMATE; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; SYRINGE NEEDLE; TARGET CELL; TRANSDERMAL PATCH; TREATMENT DURATION; TUBERCULIN TEST; VIRUS IMMUNITY; VIRUS LIKE AGENT; VIRUS RECOMBINANT; VIRUS TITRATION; ANIMAL; IMMUNIZATION; IMMUNOLOGY; SKIN;

ANIMALS; HUMANS; IMMUNIZATION; INFLUENZA VACCINES; SKIN; VACCINES, DNA;

EID: 84921646983     PISSN: 0070217X     EISSN: 21969965     Source Type: Book Series    
DOI: 10.1007/82_2014_407     Document Type: Article

References (107)

1. Abdelsadik A, Trad A (2011) Toll-like receptors on the fork roads between innate and adaptive immunity. Hum Immunol 72:1188–1193. doi:10.1016/j.humimm.2011.08.015.
2. Alarcon JB, Hartley AW, Harvey NG, Mikszta JA (2007) Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clin Vaccine Immunol 14:375–381. doi:10.1128/CVI.00387-06.
3. Albrecht CM, Sweitzer NK, Johnson MR, Vardeny O (2014) Lack of persistence of influenza vaccine antibody titers in patients with heart failure. J Card Fail 20:105–109. doi:10.1016/j.cardfail.2013.12.008.
4. Ansaldi F, Valle L, de Florentiis D, Parodi V, Murdaca G, Bruzzone B, Durando P, Setti M, Icardi G (2012) Phase 4. randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults. Hum Vaccin Immunother 8:1048–1052. doi:10.4161/hv.20347.
5. Atkinson WL, Pickering LK, Schwartz B, Weniger BG, Iskander JK, Watson JC (2002) General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR Recomm Rep 51:1–35.
6. Auewarakul P, Kositanont U, Sornsathapornkul P, Tothong P, Kanyok R, Thongcharoen P (2007) Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine 25:659–63. doi:10.1016/j.vaccine.2006.08.026.
7. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245–252.
8. Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Van Hoecke C, Howe BJ, Dubin G (2004) Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 351:2286–94. doi:10.1056/NEJMoa043555.
9. Belshe RB, Newman FK, Wilkins K, Graham IL, Babusis E, Ewell M, Frey SE (2007) Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine 25:6755–6763. doi:10.1016/j.vaccine.2007.06.066.
10. Beran J, Ambrozaitis A, Laiskonis A, Mickuviene N, Bacart P, Calozet Y, Demanet E, Heijmans S, Van Belle P, Weber F, Salamand C (2009) Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med 7:13. doi:10.1186/1741-7015-7-13.
11. Boger WP, Liu OC (1957) Subcutaneous and intradermal vaccination with Asian influenza vaccine. J Am Med Assoc 165:1687–1689.
12. Bragstad K, Martel CJ, Thomsen JS, Jensen KL, Nielsen LP, Aasted B, Fomsgaard A (2011) Pandemic influenza 1918. H1N1. and 1968. H3N2. DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades. Influenza Other Respir Viruses 5:13–23. doi:10.1111/j.1750-2659.2010.00177.x
13. Brown H, Kasel JA, Freeman DM, Moise LD, Grose NP, Couch RB (1977) The immunizing effect of influenza A/New Jersey/76 (Hsw1N1) virus vaccine administered intradermally and intramuscularly to adults. J Infect Dis 136(Suppl):S466–471.
14. Bruyn HB, Meiklejohn G, Brainerd H (1949a) Influenza vaccine; a study of serologic responses and incidence of reactions following subcutaneous and intradermal inoculation. Am J Dis Child 77:149–163.
15. Bruyn HB, Meiklejohn G, Brainerd HD (1949b) Influenza vaccination; a comparison of antibody response obtained by various methods of administration. J Immunol 62:1–11.
16. Chen D, Erickson CA, Endres RL, Periwal SB, Chu Q, Shu C, Maa YF, Payne LG (2001a) Adjuvantation of epidermal powder immunization. Vaccine 19:2908–2917.
17. Chen D, Weis KF, Chu Q, Erickson C, Endres R, Lively CR, Osorio J, Payne LG (2001b) Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses. J Virol 75:11630–11640.
18. Chen D, Endres R, Maa YF, Kensil CR, Whitaker-Dowling P, Trichel A, Youngner JS, Payne LG (2003) Epidermal powder immunization of mice and monkeys with an influenza vaccine. Vaccine 21:2830–2836.
19. Chen D, Burger M, Chu Q, Endres R, Zuleger C, Dean H, Payne LG (2004) Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity. Virus Res 103:147–153. doi:10.1016/j.virusres.2004.02.027.
20. Choi HJ, Yoo DG, Bondy BJ, Quan FS, Compans RW, Kang SM, Prausnitz MR (2012) Stability of influenza vaccine coated onto microneedles. Biomaterials 33:3756–3769. doi:10.1016/j.biomaterials.2012.01.054.
21. Choi HJ, Bondy BJ, Yoo DG, Compans RW, Kang SM, Prausnitz MR (2013) Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles. J Control Release 166:159–171. doi:10.1016/j.jconrel.2012.12.002.
22. Combadiere B, Vogt A, Mahe B, Costagliola D, Hadam S, Bonduelle O, Sterry W, Staszewski S, Schaefer H, van der Werf S, Katlama C, Autran B, Blume-Peytavi U (2010) Preferential amplification of CD8. effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial. PLoS One 5:e10818. doi:10.1371/journal.pone.0010818.
23. Dean HJ, Chen D (2004) Epidermal powder immunization against influenza. Vaccine 23:681–686. doi:10.1016/j.vaccine.2004.06.041.
24. del Pilar Martin M, Seth S, Koutsonanos DG, Jacob J, Compans RW, Skountzou I (2010) Adjuvanted influenza vaccine administered intradermally elicits robust long-term immune responses that confer protection from lethal challenge. PLoS One 5:e10897. doi:10.1371/journal.pone.0010897.
25. del Pilar Martin M, Weldon WC, Zarnitsyn VG, Koutsonanos DG, Akbari H, Skountzou I, Jacob J, Prausnitz MR, Compans RW (2012) Local response to microneedle-based influenza immunization in the skin. MBio 3:e00012–12. doi:10.1128/mBio.00012-12.
26. Depelsenaire AC, Meliga SC, McNeilly CL, Pearson FE, Coffey JW, Haigh OL, Flaim CJ, Frazer IH, Kendall MA (2014) Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicity. J Invest Dermatol. doi:10.1038/jid.2014.174.
27. Ding Z, Verbaan FJ, Bivas-Benita M, Bungener L, Huckriede A, van den Berg DJ, Kersten G, Bouwstra JA (2009) Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice. J Control Release 136:71–78. doi:10.1016/j.jconrel.2009.01.025.
28. Dupasquier M, Stoitzner P, van Oudenaren A, Romani N, Leenen PJ (2004) Macrophages and dendritic cells constitute a major subpopulation of cells in the mouse dermis. J Invest Dermatol 123:876–879. doi:10.1111/j.0022-202X.2004.23427.x
29. FaDA (FDA) (2011) FDA updated communication on use of jet injectors with inactivated influenza vaccines. Food and Drug Administration, Washington, DC
30. Fernando GJ, Chen X, Prow TW, Crichton ML, Fairmaid EJ, Roberts MS, Frazer IH, Brown LE, Kendall MA (2010) Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model. PLoS One 5:e10266. doi:10.1371/ journal.pone.0010266.
31. Fernando GJ, Chen X, Primiero CA, Yukiko SR, Fairmaid EJ, Corbett HJ, Frazer IH, Brown LE, Kendall MA (2012) Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses. J Control Release 159:215–221. doi:10.1016/j.jconrel.2012.01.030.
32. Francis T, Magill TP (1937) The antibody response of human subjects vaccinated with the virus of human influenza. J Exp Med 65:251–259.
33. Frech SA, Kenney RT, Spyr CA, Lazar H, Viret JF, Herzog C, Gluck R, Glenn GM (2005) Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch. Vaccine 23:946–950. doi:10.1016/j.vaccine.2004.06.036.
34. Frolov VG, Seid RC Jr, Odutayo O, Al-Khalili M, Yu J, Frolova OY, Vu H, Butler BA, Look JL, Ellingsworth LR, Glenn GM (2008) Transcutaneous delivery and thermostability of a dry trivalent inactivated influenza vaccine patch. Influenza Other Respir Viruses 2:53–60. doi:10. 1111/j.1750-2659.2008.00040.x
35. Fynan EF, Robinson HL, Webster RG (1993a) Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine. DNA Cell Biol 12:785–789.
36. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL (1993b) DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 90:11478–11482.
37. Garg S, Hoelscher M, Belser JA, Wang C, Jayashankar L, Guo Z, Durland RH, Katz JM, Sambhara S (2007) Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice. Clin Vaccine Immunol 14:926–928. doi:10.1128/CVI.00450-06.
38. Gill HS, Denson DD, Burris BA, Prausnitz MR (2008) Effect of microneedle design on pain in human volunteers. Clin J Pain 24:585–594. doi:10.1097/AJP.0b013e31816778f9, 00002508- 200809000-00005.
39. Giudice EL, Campbell JD (2006) Needle-free vaccine delivery. Adv Drug Deliv Rev 58:68–89.
40. Glazier MM, Benenson AS, Wheeler RE (1956) Active immunization with influenza virus A and B in infants and children. Pediatrics 17:482–488.
41. Glenn GM, Kenney RT, Ellingsworth LR, Frech SA, Hammond SA, Zoeteweij JP (2003) Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin. Expert Rev Vaccines 2:253–267.
42. Guebre-Xabier M, Hammond SA, Ellingsworth LR, Glenn GM (2004) Immunostimulant patch enhances immune responses to influenza virus vaccine in aged mice. J Virol 78:7610–7618. doi:10.1128/JVI.78.14.7610-7618.2004.
43. Hilleman MR, Flatley FJ, Anderson SA, Luecking ML, Levinson DJ (1958) Antibody response in volunteers to Asian influenza vaccine. J Am Med Assoc 166:1134–1140.
44. Hoft DF, Blazevic A, Abate G, Hanekom WA, Kaplan G, Soler JH, Weichold F, Geiter L, Sadoff JC, Horwitz MA (2008) A new recombinant bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. J Infect Dis 198:1491–1501. doi:10.1086/592450.
45. Hung IF, Levin Y, To KK, Chan KH, Zhang AJ, Li P, Li C, Xu T, Wong TY, Yuen KY (2012) Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009. H1N1. strain. Vaccine 30:6427–6435. doi:10.1016/j.vaccine.2012.08.014.
46. Icardi G, Orsi A, Ceravolo A, Ansaldi F (2012) Current evidence on intradermal influenza vaccines administered by Soluvia licensed micro injection system. Hum Vaccin Immunother 8:67–75. doi:10.4161/hv.8.1.18419.
47. Ismach A (1960) Jet injector. http://www.scienceheroes.com/index.php?option=com_content&view=article&id=166&Itemid=165.
48. Itano AA, McSorley SJ, Reinhardt RL, Ehst BD, Ingulli E, Rudensky AY, Jenkins MK (2003) Distinct dendritic cell populations sequentially present antigen to CD4. T cells and stimulate different aspects of cell-mediated immunity. Immunity 19:47–57.
49. Jackson LA, Austin G, Chen RT, Stout R, DeStefano F, Gorse GJ, Newman FK, Yu O, Weniger BG, Vaccine Safety Datalink Study G (2001) Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors. Vaccine 19:4703–4709.
50. Jones S, Evans K, McElwaine-Johnn H, Sharpe M, Oxford J, Lambkin-Williams R, Mant T, Nolan A, Zambon M, Ellis J, Beadle J, Loudon PT (2009) DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial. Vaccine 27:2506–2512. doi:10.1016/j.vaccine.2009.02.061.
51. Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR (2010a) Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. J Control Release 142:187–95. doi: 10.1016/j.jconrel.2009.10.013, S0168-3659(09)00708-1.
52. Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR (2010b) Formulation of microneedles coated with influenza virus-like particle vaccine. AAPS PharmSciTech 11:1193–1201. doi:10.1208/s12249-010-9471-3.
53. Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR (2011) Stability kinetics of influenza vaccine coated onto microneedles during drying and storage. Pharm Res 28:135–144. doi:10.1007/s11095-010-0134-6.
54. Kim YC, Jarrahian C, Zehrung D, Mitragotri S, Prausnitz MR (2012) Delivery systems for intradermal vaccination. Curr Top Microbiol Immunol 351:77–112. doi:10.1007/82_2011_123.
55. Kim YK, Eun BW, Kim NH, Kang EK, Lee BS, Kim DH, Lim JS (2013) Comparison of immunogenicity and reactogenicity of split versus subunit influenza vaccine in Korean children aged 6-35. months. Scand J Infect Dis 45:460–468. doi:10.3109/00365548.2012.755267.
56. Kommareddy S, Baudner BC, Oh S, Kwon SY, Singh M, O’Hagan DT (2012) Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens. J Pharm Sci 101:1021–1027. doi:10.1002/jps.23019.
57. Kommareddy S, Baudner BC, Bonificio A, Gallorini S, Palladino G, Determan AS, Dohmeier DM, Kroells KD, Sternjohn JR, Singh M, Dormitzer PR, Hansen KJ, O’Hagan DT (2013) Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs. Vaccine 31:3435–3441. doi:10.1016/j.vaccine.2013.01.050.
58. Koutsonanos DG, del Pilar Martin M, Zarnitsyn VG, Sullivan SP, Compans RW, Prausnitz MR, Skountzou I (2009) Transdermal influenza immunization with vaccine-coated microneedle arrays. PLoS One 4:e4773. doi:10.1371/journal.pone.0004773.
59. Koutsonanos DG, del Pilar Martin M, Zarnitsyn VG, Jacob J, Prausnitz MR, Compans RW, Skountzou I (2011) Serological memory and long-term protection to novel H1N1. influenza virus after skin vaccination. J Infect Dis 204:582–591. doi:10.1093/infdis/jir094.
60. Koutsonanos DG, Vassilieva EV, Stavropoulou A, Zarnitsyn VG, Esser ES, Taherbhai MT, Prausnitz MR, Compans RW, Skountzou I (2012) Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection. Sci Rep 2:357. doi:10.1038/srep00357.
61. Kunzi V, Klap JM, Seiberling MK, Herzog C, Hartmann K, Kursteiner O, Kompier R, Grimaldi R, Goudsmit J (2009) Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration. Vaccine 27:3561–3567. doi:10.1016/j.vaccine.2009.03.062.
62. Laurent PE, Bonnet S, Alchas P, Regolini P, Mikszta JA, Pettis R, Harvey NG (2007) Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 25:8833–8842. doi:10.1016/j.vaccine.2007.10.020, S0264-410X(07)01156-5.
63. Locati M, Allavena P, Sozzani S, Mantovanii A (2000) Shaping and tuning of the chemokine system by regulation of receptor expression and signaling: dendritic cells as a paradigm. J Neuroimmunol 107:174–177.
64. Mantoux C (1909) Tuberculin intradermo reactions in the treatment of tuberculosis: Intradermituberculisation. Comptes Rendus Hebdomadaires Des Seances De L Academie Des Sci 148:996–998.
65. Matsuo K, Hirobe S, Yokota Y, Ayabe Y, Seto M, Quan YS, Kamiyama F, Tougan T, Horii T, Mukai Y, Okada N, Nakagawa S (2012) Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza. J Control Release 160:495–501. doi:10.1016/j.jconrel.2012.04.001.
66. Moylett EH, Hanson IC (2004) Mechanistic actions of the risks and adverse events associated with vaccine administration. J Allergy Clin Immunol 114:1010–20; quiz 1021.
67. Norman JJ, Arya JM, McClain MA, Frew PM, Meltzer MI, Prausnitz MR (2014) Microneedle patches: usability and acceptability for self-vaccination againt influenza. Vaccine. 32(16):1856–62. doi: 10.1016/j.vaccine.2014.01.076. Epub 2014. Feb 11. PMID: 24530146. [PubMed - in process]
68. Ogunremi O, Pasick J, Berhane Y (2013) Needle-free delivery of an inactivated avian influenza H5N3. virus vaccine elicits potent antibody responses in chickens. Can J Vet Res 77:309–313.
69. Osterholm MT, Kelley NS, Sommer A, Belongia EA (2012) Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 12:36–44. doi:10.1016/S1473-3099(11)70295-X
70. Pearton M, Kang SM, Song JM, Anstey AV, Ivory M, Compans RW, Birchall JC (2010a) Changes in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines. PLoS One 5:e12410. doi:10.1371/journal.pone.0012410.
71. Pearton M, Kang SM, Song JM, Kim YC, Quan FS, Anstey A, Ivory M, Prausnitz MR, Compans RW, Birchall JC (2010b) Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin. Vaccine 28:6104-13. doi: 10.1016/j.vaccine.2010.05.055, S0264-410X(10)00764-4.
72. Pearton M, Pirri D, Kang SM, Compans RW, Birchall JC (2013) Host responses in human skin after conventional intradermal injection or microneedle administration of virus-like-particle influenza vaccine. Adv Healthc Mater 2:1401–1410. doi:10.1002/adhm.201300006.
73. Quan FS, Kim YC, Yoo DG, Compans RW, Prausnitz MR, Kang SM (2009) Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin. PLoS One 4:e7152. doi:10.1371/journal.pone.0007152.
74. Quan FS, Kim YC, Compans RW, Prausnitz MR, Kang SM (2010a) Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles. J Control Release 147:326–332. doi:10.1016/j.jconrel.2010.07.125.
75. Quan FS, Kim YC, Vunnava A, Yoo DG, Song JM, Prausnitz MR, Compans RW, Kang SM (2010b) Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization. J Virol 84:7760-9. doi:10.1128/JVI.01849-09JVI.01849-09.
76. Quan FS, Kim YC, Song JM, Hwang HS, Compans RW, Prausnitz MR, Kang SM (2013) Longterm protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch. Clin Vaccine Immunol. doi:10.1128/CVI.00251-13.
77. Rao S, Kong WP, Wei CJ, Yang ZY, Nason M, Styles D, DeTolla LJ, Panda A, Sorrell EM, Song H, Wan H, Ramirez-Nieto GC, Perez D, Nabel GJ (2008) Multivalent HA DNA vaccination protects against highly pathogenic H5N1. avian influenza infection in chickens and mice. PLoS One 3:e2432. doi:10.1371/journal.pone.0002432.
78. Raphael AP, Prow TW, Crichton ML, Chen X, Fernando GJ, Kendall MA (2010) Targeted, needle-free vaccinations in skin using multilayered, densely-packed dissolving microprojection arrays. Small 6:1785–1793. doi:10.1002/smll.201000326.
79. Riedel S (2005) Edward Jenner and the history of smallpox and vaccination. Proc (Bayl Univ Med Cent) 18:21–25.
80. Romani N, Tschachler E, Schuler G, Aberer W, Ceredig R, Elbe A, Wolff K, Fritsch PO, Stingl G (1985) Morphological and phenotypical characterization of bone marrow-derived dendritic Thy-1-positive epidermal cells of the mouse. J Invest Dermatol 85:91s–95s
81. Romani N, Flacher V, Tripp CH, Sparber F, Ebner S, Stoitzner P (2012) Targeting skin dendritic cells to improve intradermal vaccination. Curr Top Microbiol Immunol 351:113–138. doi:10.1007/82_2010_118.
82. Sencer DJ, Millar JD (2006) Reflections on the 1976. swine flu vaccination program. Emerg Infect Dis 12:29–33. doi:10.3201/eid1201.051007.
83. Skountzou I, Kang SM (2009) Transcutaneous immunization with influenza vaccines. Curr Top Microbiol Immunol 333:347–368. doi:10.1007/978-3-540-92165-3_17.
84. Skountzou I, Quan FS, Jacob J, Compans RW, Kang SM (2006) Transcutaneous immunization with inactivated influenza virus induces protective immune responses. Vaccine 24:6110–6119. doi:10.1016/j.vaccine.2006.05.014.
85. Song JM, Kim YC, Barlow PG, Hossain MJ, Park KM, Donis RO, Prausnitz MR, Compans RW, Kang SM (2010a) Improved protection against avian influenza H5N1. virus by a single vaccination with virus-like particles in skin using microneedles. Antiviral Res 88:244–247. doi:10.1016/j.antiviral.2010.09.001.
86. Song JM, Kim YC, Lipatov AS, Pearton M, Davis CT, Yoo DG, Park KM, Chen LM, Quan FS, Birchall JC, Donis RO, Prausnitz MR, Compans RW, Kang SM (2010b) Microneedle delivery of H5N1. influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice. Clin Vaccine Immunol 17:1381–1389. doi:10.1128/CVI.00100-10.
87. Song JM, Kim YC, O E Compans RW, Prausnitz RW, Kang (2012) DNA vaccination in the skin using microneedles improves protection against influenza. Mol Ther 20:1472–1480. doi:10. 1038/mt.2012.69.
88. Sozzani S, Allavena P, Vecchi A, Mantovani A (2000) Chemokines and dendritic cell traffic. J Clin Immunol 20:151–260.
89. Sparber F, Tripp CH, Hermann M, Romani N, Stoitzner P (2010) Langerhans cells and dermal dendritic cells capture protein antigens in the skin: possible targets for vaccination through the skin. Immunobiology 215:770–779. doi:10.1016/j.imbio.2010.05.014.
90. Sullivan SP, Koutsonanos DG, del Pilar Martin M, Lee JW, Zarnitsyn V, Choi SO, Murthy N, Compans RW, Skountzou I, Prausnitz MR (2010) Dissolving polymer microneedle patches for influenza vaccination. Nat Med 16:915–920. doi:10.1038/nm.2182.
91. Tauraso NM, Gleckman R, Pedreira FA, Sabbaj J, Yahwak R, Madoff MA (1969) Effect of dosage and route of inoculation upon antigenicity of inactivated influenza virus vaccine (Hong Kong strain) in man. Bull World Health Organ 41:507–516.
92. Teunissen MBM (2012) Intradermal Immunization. Current topics in microbiology and immunology, vol 351.
93. Valladeau J, Ravel O, Dezutter-Dambuyant C, Moore K, Kleijmeer M, Liu Y, Duvert-Frances V, Vincent C, Schmitt D, Davoust J, Caux C, Lebecque S, Saeland S (2000) Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12:71–81.
94. Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y (2009) Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 27:454–459. doi:10.1016/j.vaccine.2008.10.077.
95. Van Gelder DW, Greenspan FS, Dufresne NE (1947) Influenza vaccination; comparison of intracutaneous and subcutaneous methods. U S Nav Med Bull 47:197–206.
96. Van Kampen KR, Shi Z, Gao P, Zhang J, Foster KW, Chen DT, Marks D, Elmets CA, Tang DC (2005) Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans. Vaccine 23:1029–1036. doi:10.1016/j.vaccine.2004.07.043.
97. Wang BZ, Gill HS, He C, Ou C, Wang L, Wang YC, Feng H, Zhang H, Prausnitz MR, Compans RW (2014) Microneedle delivery of an M2e-TLR5. ligand fusion protein to skin confers broadly cross-protective influenza immunity. J Control Release 178:1–7. doi:10.1016/j.jconrel.2014.01.002.
98. Weir E, Hatch K (2004) Preventing cold chain failure: vaccine storage and handling. Cmaj 171:1050.
99. Weldon WC, del Pilar Martin MP, Zarnitsyn V, Wang B, Koutsonanos D, Skountzou I, Prausnitz MR, Compans RW (2011) Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity. Clin Vaccine Immunol 18:647–654. doi:10.1128/CVI.00435-10.
100. Weldon WC, Zarnitsyn VG, Esser ES, Taherbhai MT, Koutsonanos DG, Vassilieva EV, Skountzou I, Prausnitz MR, Compans RW (2012) Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine. PLoS One 7:e41501. doi:10.1371/journal.pone.0041501.
101. Weller TH, Cheever FS, Enders JF (1948) Immunologic reactions following the intradermal inoculation of influenza A and B vaccine. Proc Soc Exp Biol Med 67:96–101.
102. Weniger BG, Glenn GM (2013) Cutaneous vaccination: antigen delivery into or onto the skin. Vaccine 31:3389–3391. doi:10.1016/j.vaccine.2013.05.048.
103. WHO (WHO) (2005) Solutions: Choosing Technologies for Safe Injections. Accessed 2011-05- 06 2011.
104. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL (1990) Direct gene transfer into mouse muscle in vivo. Science 247:1465–1468.
105. Wrammert J, Koutsonanos D, Li GM, Edupuganti S, Sui J, Morrissey M, McCausland M, Skountzou I, Hornig M, Lipkin WI, Mehta A, Razavi B, Del Rio C, Zheng NY, Lee JH, Huang M, Ali Z, Kaur K, Andrews S, Amara RR, Wang Y, Das SR, O’Donnell CD, Yewdell JW, Subbarao K, Marasco WA, Mulligan MJ, Compans R, Ahmed R, Wilson PC (2011) Broadly cross-reactive antibodies dominate the human B cell response against 2009. pandemic H1N1. influenza virus infection. J Exp Med 208:181–93. doi: 10.1084/jem.20101352, S0166-3542(10)00705-9.
106. Yewdell JW, Bennink JR, Smith GL, Moss B (1985) Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci USA 82:1785–1789.
107. Zhu Q, Zarnitsyn VG, Ye L, Wen Z, Gao Y, Pan L, Skountzou I, Gill HS, Prausnitz MR, Yang C, Compans RW (2009) Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge. Proc Natl Acad Sci USA 106:7968–7973. doi:10.1073/pnas.0812652106